The Emerging Solutions in Pain Responsible Opioid Prescribing Series

Please Log In or Register to continue.

Release Date: March 31, 2014
Expiration Date: March 31, 2015

Expected time to complete this activity as designed: 3 hours for all six modules
There are no fees for participating in or receiving credit for this online activity.

Program Overview

The Emerging Solutions in Pain Responsible Opioid Prescribing Activity is designed to improve the knowledge and competence of physicians, nurse practitioners, and dentists in the safe and responsible prescribing of ER/LA opioids, and to support the implementation of best practice standards for prescribing ER/LA opioids in routine clinical practice. The activity will stress the importance of treatment strategies that minimize the risk of serious adverse events, including addiction and death, which may be associated with the ER/LA opioids, and will provide participants with tools and resources for communicating with chronic pain patients who may be candidates for treatment with these analgesic agents.

Target Audience

This activity is designed for physicians and nurse practitioners who are registered with the DEA, eligible to prescribe Schedule 2 and 3 drugs, and who have written at least one prescription for an ER/LA opioid in the previous 12 month period, and dentists who prescribe ER/LA opioids.

Learning Objectives

Module 1
Patient Assessment for Treatment with ER/LA Opioid Analgesia

Upon completion of this educational activity, participants should be able to:

  • Describe how to assess patients for treatment with an ER/LA opioid analgesic

Module 2
Treating Patients with ER/LA Opioid Analgesics; Initiating, Modifying, and Discontinuing Therapy

Upon completion of this educational activity, participants should be able to:

  • Demonstrate how to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics

Module 3
Managing Therapy with ER/LA Opioids

Upon completion of this educational activity, participants should be able to:

  • Recognize how to manage ongoing therapy with ER/LA opioid analgesics

Module 4
The Patient as an Integrated Member of the Treatment Team: Clinical Steps for Effective Patient Education

Upon completion of this educational activity, participants should be able to:

  • Employ strategies and implement process of counseling patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal

Module 5
ER/LA Opioid Analgesics: Applied Pharmacology in the Clinical Setting

Upon completion of this educational activity, participants should be able to:

  • Recall general drug information regarding ER/LA opioid analgesics

Module 6
Clinician Guide to the ER/LA Opioid Analgesics

Upon completion of this educational activity, participants should be able to:

  • Recall product-specific drug information related to ER/LA opioid analgesics

Agenda

Module 1: Patient Assessment for Treatment with ER/LA Opioid Analgesia – Jeffrey A. Gudin, MD, and W. Clay Jackson, MD, DipTh

Module 2: Treating Patients with ER/LA Opioid Analgesics; Initiating, Modifying, and Discontinuing Therapy – Jeffrey A. Gudin, MD, and Bill McCarberg, MD, FABPM

Module 3: Managing Therapy with ER/LA Opioids – Jeffrey A. Gudin, MD, and Bill McCarberg, MD, FABPM

Module 4: The Patient as an Integrated Member of the Treatment Team: Clinical Steps for Effective Patient Education – Jeffrey A. Gudin, MD, and W. Clay Jackson, MD, DipTh

Module 5: ER/LA Opioid Analgesics: Applied Pharmacology in the Clinical Setting – Jeffrey A. Gudin, MD, and Bill McCarberg, MD, FABPM

Module 6: Clinician Guide to the ER/LA Opioid Analgesics – Jeffrey A. Gudin, MD, and Bill McCarberg, MD, FABPM

Instructions for Participation and Credit

This activity is eligible for credit through March 31, 2015. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You will be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates may be printed immediately after viewing all six modules in the activity, and successfully completing all six post-tests and evaluations.

Faculty Biographies

Jeffrey A. Gudin, MD
Director
Pain Management and Palliative Care
Englewood Hospital and Medical Center
Englewood, New Jersey

Dr. Jeffrey A. Gudin received his medical degree from Albany Medical College in Albany, New York. Following a transitional internship in surgery, medicine, and anesthesiology at St. Barnabas Medical Center in Livingston, New Jersey, he completed a residency in anesthesiology at Yale University School of Medicine. Dr. Gudin continued his training with an extended postdoctoral fellowship in pain medicine at the Yale Center for Pain Management, where he was actively involved in research and teaching. He is currently director of Pain Management and Palliative Care at Englewood Hospital and Medical Center, a Mount Sinai School of Medicine teaching affiliate in New Jersey.

Dr. Gudin is board certified in pain management, anesthesiology, addiction medicine, and hospice and palliative care medicine. He remains active in teaching and research, and has lectured internationally on a variety of topics in pain management and addiction medicine.

W. Clay Jackson, MD, DipTh
Clinical Assistant Professor of Psychiatry
University of Tennessee College of Medicine
Memphis, Tennessee

Dr. W. Clay Jackson is a clinical assistant professor of psychiatry at the University of Tennessee College of Medicine in Memphis where he also maintains a private practice in family and palliative medicine. In addition, Dr. Jackson is the president and medical director of Comprehensive Primary Care, medical director of Methodist Alliance Hospice and Palliative Services, and a fellowship director of palliative medicine at the University of Tennessee College of Medicine. Dr. Jackson is board certified in family practice and hospice and palliative medicine, and has presented at national conferences on the treatment of chronic pain. His work has been published in a number of leading academic journals and he is a recipient of numerous teaching honors.

Bill McCarberg, MD, FABPM
Founder
Chronic Pain Management Program
Kaiser Permanente
San Diego, California

Dr. Bill McCarberg received his medical degree from Northwestern University Feinberg School of Medicine in Chicago. He completed both his internship and residency in family practice at Highland Hospital in Rochester, New York. Dr. McCarberg is a founding member of the Chronic Pain Management Program at Kaiser Permanente, San Diego, California, and is adjunct assistant clinical professor at University of California, San Diego School of Medicine.

Dr. McCarberg is board certified by the American College of Pain Medicine, American Board of Family Practice, and additionally certified in geriatrics. He is president of the Western Pain Society, serves on the Board of Directors of the American Academy of Pain Medicine, and was previously on the Board of Directors for the American Pain Society. Additionally, Dr. McCarberg is a member of the American Academy of Family Physicians, American Academy of Pain Medicine, American Pain Society, and International Association for the Study of Pain. He has given more than 250 presentations on pain management issues and authored more than 75 articles, book chapters, and books. He is the recipient of several prestigious awards, including the Shilling Compassionate Care Award, the Elizabeth Narcessian Award for leader in the field of pain education from the American Pain Society, and was Ambassador of the Year for the National Pain Foundation.

Accreditation

AAPain Mgmt CME CREDIT
The American Academy of Pain Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Academy of Pain Management designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP AANP CE CREDIT
This program is approved for 3.0 contact hours of continuing education (which includes 1.0 hour of pharmacology) by the American Association of Nurse Practitioners. Program ID 1402105. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.


MediCom CDE CREDIT
AEGIS Publications, LLC, is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to ADA CERP at www.ada.org/cerp.

Approved PACE Program Provider FAGD/MAGD Credit
Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. 1/1/2013 to 12/31/2016. Provider ID# 209722
This course has been planned and implemented in accordance with the American Dental Association and the Academy of General Dentistry standards. Dental Learning Systems designates this educational activity for 3 CE credits. Course is valid from March 17, 2014 to March 31, 2017. Participants must attain a score of 70% on each quiz to receive credit. Participants receiving a failing grade on any exam will be notified and permitted to one re-examination.

Faculty Disclosures

Dr. Jeffrey Gudin has received consultant fees from Alere and Nektar, as well as honoraria related to speakers’ bureau activities from Endo Pharmaceuticals Inc., Johnson & Johnson Services, Inc., Mallinckrodt Inc. (now Covidien), Purdue Pharma L.P., and Salix Pharmaceuticals, Inc.

Dr. Clay Jackson has received consulting fees from Eli Lilly and Company, Depomed, Inc., Pamlab, and Sunovion Pharmaceuticals Inc., as well as honoraria related to non-CME services from Eli Lilly and Pamlab.

Dr. Bill McCarberg has received honoraria as a consultant from Collegium Pharmaceutical, Inspirion Pharmaceuticals, Iroko Pharmaceuticals, LLC, Mallinckrodt Inc. (now Covidien), Millennium: The Takeda Oncology Company, Pfizer Inc., Salix Pharmaceuticals, Inc, and Zogenix, Inc. He has ownership interest in Johnson & Johnson Services, Inc., Protein Design Labs (now PDL BioPharma), BioSpecifics Technologies Corp, Nektar, Zogenix, Inc., and Galena Biopharma.

Planning Committee Disclosures

The individuals listed below from American Academy of Pain Management reported the following for this activity: Cathleen Coneghen, education manager, and Debra Nelson-Hogan, director of education, have no relevant financial relationships.

The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director has no relevant financial relationships. Karen Roy, MSc CCMEP, independent consultant, has received honoraria as a consultant from Genentech, Sage Products, and Vanda Pharmaceuticals.

Peer Reviewer Disclosure

In accordance with American Academy of Pain Management and MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Drs. Gudin, Jackson, and McCarberg have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Drs. Gudin, Jackson, and McCarberg have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player and/or Microsoft® Silverlight.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@emergingsolutionsinpain.com.

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

©2014 American Academy of Pain Management, 975 Morning Star Drive, Suite A, Sonora, CA 95370, 209-533-9744

No portion of this material may be copied or duplicated without the expressed permission of American Academy of Pain Management

Please Log In or Register to continue.